OTCPK:IGNG

Stock Analysis Report

Executive Summary

Imaging3 Inc., a development stage medical device company, provides a portable proprietary imaging technology designed to produce 3D x-ray images in real time.

Snowflake

Worrying balance sheet with weak fundamentals.

Risk Analysis

Does not have meaningful revenue ($27K)



Similar Companies

Share Price & News

How has Imaging3's share price performed over time and what events caused price changes?


Latest Share Price and Events

Information is not available.


Market Performance


7 Day Return

-11.3%

IGNG

-0.2%

US Medical Equipment

0.3%

US Market


1 Year Return

-64.4%

IGNG

17.7%

US Medical Equipment

12.5%

US Market

Information is not available.

Information is not available.


Shareholder returns

IGNGIndustryMarket
7 Day-11.3%-0.2%0.3%
30 Day30.0%2.0%4.1%
90 Day1504.9%-0.7%5.6%
1 Year-64.4%-64.4%18.7%17.7%15.0%12.5%
3 Yearn/a84.3%78.7%49.1%39.4%
5 Yearn/a114.0%90.7%62.8%44.7%

Price Volatility Vs. Market

How volatile is Imaging3's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Imaging3 undervalued compared to its fair value and its price relative to the market?


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate IGNG's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate IGNG's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: IGNG is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.

PE vs Market: IGNG is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate IGNG's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: IGNG has negative assets, so we can't compare its PB Ratio to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Imaging3 forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

23.2%

Forecasted Healthcare industry annual growth in earnings


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if IGNG's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if IGNG's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if IGNG's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if IGNG's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Information is not available.


Next Steps

Past Performance

How has Imaging3 performed over the past 5 years?

-27.9%

Historical annual earnings growth


Earnings and Revenue History

Information is not available.

Information is not available.


Past Earnings Growth Analysis

Earnings Trend: IGNG is unprofitable, and losses have increased over the past 5 years at a rate of -27.9% per year.

Accelerating Growth: Unable to compare IGNG's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: IGNG is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (22.5%).


Return on Equity

High ROE: IGNG's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Imaging3's financial position?


Financial Position Analysis

Short Term Liabilities: IGNG has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: IGNG has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: IGNG has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: IGNG's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet

Information is not available.

Information is not available.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: IGNG has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: IGNG has less than a year of cash runway if free cash flow continues to reduce at historical rates of -12.9% each year


Next Steps

Dividend

What is Imaging3's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.2%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate IGNG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate IGNG's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if IGNG's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if IGNG's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IGNG's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Imaging3's salary, the management and board of directors tenure and is there insider trading?

1.4yrs

Average board tenure


CEO

John Hollister (57yo)

1.5yrs

Tenure

US$219,000

Compensation

Mr. John B. Hollister, MBA has been Chief Executive Officer of Imaging3, Inc. since December 19, 2017 and served as its Chairman since December 19, 2017. Mr. Hollister served as a Director of Imaging3, Inc ...


CEO Compensation Analysis

Information is not available.

Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.


Board Age and Tenure

1.4yrs

Average Tenure

Experienced Board: IGNG's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Information is not available.


Management Team

  • John Hollister (57yo)

    Chief Executive Officer

    • Tenure: 1.5yrs
    • Compensation: US$219.00k
  • Joe Biehl (64yo)

    Executive VP & CFO

    • Tenure: 1.3yrs
    • Compensation: US$49.50k

Board Members

  • George Zdasiuk (66yo)

    Chairman of Scientific Advisory Board & Director

    • Tenure: 1.2yrs
    • Compensation: US$20.00k
  • Jeff Peterson (63yo)

    Chairman

    • Tenure: 0yrs
    • Compensation: US$45.00k
  • Douglas Beall

    Member of Scientific Advisory Board

    • Tenure: 1.4yrs
  • E. Spencer

    Member of Scientific Advisory Board

    • Tenure: 1.4yrs

Company Information

Imaging3, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Imaging3, Inc.
  • Ticker: IGNG
  • Exchange: OTCPK
  • Founded: 1993
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$7.008m
  • Shares outstanding: 53.90m
  • Website: https://www.imaging3.com

Number of Employees


Location

  • Imaging3, Inc.
  • 4919 Noeline Avenue
  • Encino
  • California
  • 91436
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IGNGOTCPK (Pink Sheets LLC)YesNew Common StockUSUSDJun 2016

Biography

Imaging3 Inc., a development stage medical device company, provides a portable proprietary imaging technology designed to produce 3D x-ray images in real time. The company’s lead device, the Dominion Smart ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/06/04 00:43
End of Day Share Price2019/06/03 00:00
Earnings2019/03/31
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.